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Autophagy is a lysosomal degradationpathway that is
important in cellular homeostasis. Prior work showed
a key role for the autophagy related 5 (Atg5) in resis-
tance to Toxoplasma gondii. Here we show that the
cassette of autophagy proteins involved in the conju-
gation of microtubule-associated protein 1 light chain
3 (LC3) to phosphatidylethanolamine, including Atg7,
Atg3, and the Atg12-Atg5-Atg16L1 complex play
crucial roles in the control of T. gondii in vitro and
in vivo. In contrast, pharmacologic modulation of
the degradative autophagy pathway or genetic dele-
tion of other essential autophagy genes had no sub-
stantial effects. Rather the conjugation system was
required for targetingofLC3and interferon-geffectors
onto the vacuolar membrane of T. gondii and its
consequent disruption. These data suggest that the
ubiquitin-like conjugation systems that reorganize
intracellular membranes during canonical autophagy
are necessary for proper targeting of immune effec-
tors to the intracellular vacuole membranes utilized
by pathogens.
INTRODUCTION
Toxoplasma gondii is a protozoan parasite that infects a broad
range of animals and causes zoonotic toxoplasmosis in humans
(Sibley, 2011). Toxoplasmosis is a leading cause of reportable
foodborne illness in the United States and contributes to
congenital disease and opportunistic disease in immunocom-
promised persons throughout the world (Jones et al., 2010).
Although 25%–30%of theworld’s population is believed to carry
persistent T. gondii infection for life, most people remain asymp-
tomatic as long as the parasites are under the control of the924 Immunity 40, 924–935, June 19, 2014 ª2014 Elsevier Inc.immune system (Pappas et al., 2009). Therefore, understanding
how the normal immune system controls the T. gondii infection
might lead to better management of toxoplasmosis in patients,
especially the immunocompromised.
The active invasion of host cells by T. gondii leads to the
formation of the nonfusogenic parasitophorous vacuole (PV), a
cytoplasmic membranous structure that envelops the invading
T. gondii in the host cell (Sibley, 2011). Inside the PV, T. gondii
replicates by endodyogeny while protected from the inimical
host cytoplasm. To fight the T. gondii infection, cells are armed
with effector molecules, such as the immunity-related p47
GTPases (IRGs) and guanylate-binding proteins (GBPs), induced
by cellular activation through interferon-g (IFN-g) secretion by
immune cells and its subsequent binding to host cell receptors
(Howard et al., 2011; Kim et al., 2012). These effectors rapidly
accumulate on and around the PV membrane (PVM), leading to
the disruption of PVM and subsequent death of the parasite.
The proper loading of the effectors onto the PVM is known to
require GTP-binding dependent oligomerization, which is
controlled by regulatory interactions among the effectors (Ho-
ward et al., 2011). Moreover, we and others showed that the
essential autophagy gene Atg5 (autophagy related 5) is required
for the proper targeting of the effectors onto the PVM of T. gondii
(Selleck et al., 2013; Zhao et al., 2009; 2008). Without Atg5, the
effectors are induced by IFN-g normally but form cytoplasmic
aggregates instead of accumulating on the PVM. However, the
mechanismof the Atg5-mediated targeting of the IFN-g effectors
to the PVM of T. gondii is poorly understood (Howard et al.,
2011).
Autophagy is an evolutionarily conserved intracellular degra-
dation pathway that targets cellular constituents to lysosomes
(Parzych and Klionsky, 2014). Among the different forms of auto-
phagy, macroautophagy (henceforth, autophagy) is the pathway
that sequesters cytoplasmic materials in double-membrane-
bound autophagosomes and degrades the cargo through the
fusion between the autophagosome and lysosome (Rubinsztein
et al., 2012). Upon induction of autophagy by various signals,
such as the inhibition of mammalian target of rapamycin
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ordinated 51-like kinase 1/2)-Atg13-Atg101-FIP200 (focal
adhesion kinase family-interacting protein of 200 kD) activates
the phosphatidylinositol 3-kinase (PI3K) complex of Beclin1-
Vps34-Vps15-Atg14L. This activation leads to the nucleation of
isolation membrane formation and the elongation complex of
Atg12-Atg5-Atg16L1 extends the membrane further by conju-
gating LC3 (microtubule-associated protein 1 light chain 3)
homologs to the phosphatidylethanolamine of the growing
autophagosome (Rubinsztein et al., 2012).
The function of the autophagy pathway was initially identified
as a starvation-induced homeostatic pathway for recycling of
essential materials, but in recent years it has been expanded
to include cellular remodeling, secretion, differentiation, and
immune defense (Levine et al., 2011). Specifically, the role of
autophagy in the selective recognition and subsequent lyso-
somal degradation of pathogens has been highlighted in the
innate immune defense against intracellular pathogens (Levine
et al., 2011). Furthermore, we showed that the autophagy elon-
gation complex, but not the degradative autophagy pathway,
plays an essential role in the control of murine norovirus (MNV)
by IFN-g (Hwang et al., 2012). We also found that proximal com-
ponents of the autophagy pathway including ULK1, Atg14L, and
Beclin1 are required for replication of Brucella abortus in macro-
phages while distal components of the pathway such as Atg5,
Atg7, and Atg16L1 are not (Starr et al., 2012). These observa-
tions open up the possibility that cassettes of autophagy pro-
teins play a broad role in biology independent of the canonical
degradation of cytoplasmic organelles and other constituents
(Bestebroer et al., 2013; Subramani and Malhotra, 2013).
Here we show that the conjugation of LC3 through E1 Atg7,
E2 Atg3, and E3 Atg12-Atg5-Atg16L1 complex is required to
control T. gondii infection in vitro and in vivo. Using genetic
and pharmacologic methods, we demonstrate that only the
two ubiquitin-like conjugation systems of the autophagy
pathway, but not the canonical degradative autophagy process
nor the initiation-nucleation complex, are required for IFN-g to
control T. gondii infection. These data suggest that the ubiqui-
tin-like conjugation systems, which are normally involved in the
reorganization of intracellular membranes in the canonical auto-
phagy pathway, are also required for proper targeting of LC3
and IFN-g effectors toward the intracellular membrane struc-
ture of pathogens.
RESULTS
Atg5, Atg7, and Atg16L1, but Not Atg14L, Are Required
to Control T. gondii Infection In Vivo
Previously, we showed that Atg5 in myeloid lineage cells is
required for resistance of mice to infection with T. gondii (Zhao
et al., 2008). Although Atg5 was required for IFN-g induced con-
trol of T. gondii in primary macrophages, autophagosomes—the
hallmark of canonical autophagy—are not visualized in this pro-
cess. This finding led us to hypothesize that the role of Atg5
in intracellular immunity to T. gondii infection might be indepen-
dent of its role in the elongation of autophagosomal mem-
brane required for the canonical autophagy pathway (Zhao
et al., 2008). To investigate the mechanism, we examined the
role of other essential autophagy genes—Atg7, Atg14L, andAtg16L1—during the in vivo infection of T. gondii. Atg7 is the
E1 activating enzyme that is required for the activation of both
ubiquitin-like molecules, LC3 and Atg12. Atg16L1 binds to the
Atg12-conjugated Atg5 and form the autophagosome elonga-
tion complex, which is essential for the growth of autophago-
some by functioning as E3 ligase for LC3 conjugation. Atg14L
functions in endoplasmic reticulum targeting of PI3K complex
for the nucleation of the autophagosomal membrane (Matsu-
naga et al., 2010; 2009).
Because full deletion of essential autophagy genes causes
neonatal lethality, we took a conditional deletion approach (Miz-
ushima and Levine, 2010). We infected Atg7flox/flox+LysMcre,
Atg16L1flox/flox+LysMcre, Atg14Lflox/flox+LysMcre, and their con-
trol littermate mice with T. gondii. Similar to Atg5flox/flox+LysMcre
mice (Figure S1A), both Atg7flox/flox+LysMcre (Figure 1A) and
Atg16L1flox/flox+LysMcre (Figure 1B)miceweremore susceptible
to lethal infection with T. gondii than their controls. Atg7flox/flox+
LysMcre mice were less susceptible to T. gondii infection
than Atg5flox/flox+LysMcre and Atg16L1flox/flox+LysMcre mice,
possibly due to less efficient functional deletion of Atg7
by LysMcre (Figure S1B). In contrast, both Atg14Lflox/flox and
Atg14Lflox/flox+LysMcre mice showed similar resistance to the
infection of T. gondii, suggesting that Atg14L is not required to
control in vivo infection of T. gondii (Figure 1C). This lack of a
phenotype was not due to insufficient functional deletion of
Atg14L in vivo, because macrophages directly isolated from
Atg14Lflox/flox+LysMcremice have undetectable Atg14L expres-
sion and a significant accumulation of p62 protein, which is
normally removed through functional autophagy, compared to
control (Figure 1D) without significant induction of p62 mRNA
(Figure S1C). In contrast, the conversion of LC3-I (cytosolic) to
LC3-II (lipidated and membrane-bound) was largely unaffected
by the deletion of Atg14L, which is consistent with previous find-
ings (Matsunaga et al., 2009; Zhong et al., 2009). These genetic
data distinguish the role of autophagy proteins in the control of
in vivo infection of T. gondii from their role in canonical degrada-
tive autophagy that requires Atg14L.
Canonical Degradative Autophagy Pathway Is Not
Required for IFN-g to Control T. gondii Infection
To investigate the control of T. gondii by IFN-g in primary
macrophages more efficiently than provided by previous micro-
scopy-based assays (Zhao et al., 2008), we developed a flow cy-
tometry-based system to assess the level of T. gondii infection
(Figure S2A). We compared the data of the immunofluorescence
method to those of the flow cytometry method for the measure-
ment of T. gondii infection and found that these two assays per-
formed comparably (as described below). Therefore, we utilized
the flow-cytometry-based assay system for the rest of our study.
We first investigated the role of the degradative autophagy
pathway in the control of T. gondii by IFN-g by using pharmaco-
logic approaches. Degradative autophagy was induced with
treatment of an mTOR inhibitor (rapamycin) or starvation (Earle’s
Balanced Salt Solution, EBSS) and inhibited with treatment
of PI3K inhibitors (wortmannin or LY294002). Late steps of
degradative autophagy, the fusion of the autophagosome with
lysosome and subsequent degradation of its contents within
the autolysosome, were blocked with lysosomal acidification in-
hibitors (chloroquine or bafilomycin A1) or lysosomal proteaseImmunity 40, 924–935, June 19, 2014 ª2014 Elsevier Inc. 925
Figure 1. Atg7 and Atg16L1, but Not Atg14L, Are Required to Control T. gondii Infection In Vivo
(A–C) Survival curves after intraperitoneal inoculation with 200 (male) or 100 (female) of T. gondii per mouse. Number of mice is shown in parentheses.
(A) Atg7flox/flox+/LysMcre, (B) Atg16L1flox/flox+/LysMcre, (C) Atg14Lflox/flox+/LysMcre. Statistical analysis by log rank (Mantel-Cox) test.
(D) A representative protein blot and quantitative analyses of Atg14L and p62 in the peritoneal exudatemacrophages is shown. Combined data as each data point
with average. See also Figure S1.
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ifested as increased LC3-II and decreased p62, and its inhibition
leads to decreased LC3-II and increased p62, although compen-
satory feedback can occur for prolonged treatment (Hwang
et al., 2012; Mizushima et al., 2010). In contrast, lysosomal
degradation blockers increase the level of both LC3-II and p62.
The treatments with pharmacologic agents had significant and
expected effects on degradative autophagy in control cells (Fig-
ure 2A), but none of the treatments significantly affected the
control of T. gondii by IFN-g (Figure 2B). In fact, none of them,
except starvation in EBSS medium, which caused significant
death of the treated cells, significantly affected the infection level
with T. gondii (Figure S2B).
We further tested the role of the canonical autophagy pathway
in the control of T. gondii by IFN-g by using genetic approaches.
Consistent with the lack of a role for Atg14L in resistance of mice
to T. gondii infection in vivo (Figure 1C), T. gondii infection in
both control (Atg14Lflox/flox) and Atg14L-deficient macrophages
(Atg14Lflox/flox+LysMcre) was similarly inhibited by IFN-g
(Figure 2C). The ULK1 and ULK2 complex is essential in initiating
autophagosome formation, and deletion of both ULK1 and ULK2926 Immunity 40, 924–935, June 19, 2014 ª2014 Elsevier Inc.causes perinatal lethality as observed for knockout of essential
autophagy genes (McAlpine et al., 2013). Therefore, we utilized
mouse embryonic fibroblasts (MEFs) from Ulk1/Ulk2/ mice
to investigate the role of the initiation complex in the control of
T. gondii by IFN-g. Similar to the Atg14L-deficient cells, deletion
of both ULK1 and ULK2 did not affect the control of T. gondii by
IFN-g (Figure 2D). Therefore, the deletion of Atg14L in the nucle-
ation complex (Figure 2E) and ULK1 and ULK2 in the initiation
complex (Figure S2C) did not have any significant effect on the
control of T. gondii by IFN-g. Collectively, pharmacologic and
genetic modulation of the autophagy pathway showed that the
canonical degradative autophagy pathway is not required for
IFN-g to control T. gondii infection, which is consistent with
in vivo data (Figure 1).
Atg12-Atg5-Atg16L1 Complex Is Required for IFN-g to
Control T. gondii Infection In Vitro
To examine the role of Atg5 in the control of T. gondii by IFN-g,
we reconstituted Atg5-deficient macrophages with wild-type
(WT) and mutants of Atg5 by using lentiviral transduction. We
first confirmed that T. gondii infection was significantly inhibited
Figure 2. Degradative Autophagy Pathway
Is Not Required for IFN-g to Control
T. gondii Infection
(A) Protein blot for the autophagy status of the
samples as shown in (B). Samples harvested at
24 hpi.
(B) Flow cytometry analysis for the relative infec-
tion (%) of T. gondii at 24 hpi (MOI = 1) in BMDMs
from C57BL/6 mice treated with chemicals as
indicated. Cellswere treatedwith the chemicals for
24 hr ± 100 U/ml (50 ng/ml) of IFN-g before infec-
tion and treated again during the infection (total
48 hr of treatment). Autophagy inducers—rapa-
mycin, starvation (EBSS); autophagy inhibitors—
wortmannin, LY294002; degradation blockers—
chloroquine, bafilomycin A1, E64D, pepstatinA.
(C) Same analysis as shown in (B) for
Atg14Lflox/flox+/LysMcre BMDMs. Cells were
pretreated with IFN-g for 24 hr at the indicated
doses.
(D) Same analysis as shown in (B) for WT and
Ulk1/Ulk2/ MEFs.
(E) Protein blot for untreated/uninfected
Atg14Lflox/flox+/LysMcre BMDMs. Statistical
analysis by one-way ANOVA with Tukey post
test. n.s., not significant (p > 0.05), **p < 0.01,
***p < 0.001, ****p < 0.0001. Combined data as
average ± SEM. See also Figure S2.
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deficient macrophages (Atg5flox/flox+LysMcre), transduced with
control lentivirus, by using both flow cytometry (Figure 3A) and
immunofluorescence assays (Figure S3A). Transduction of WT
Atg5 into Atg5-deficient macrophage restored the control of
T. gondii by IFN-g and basal autophagy in the transduced cells,
as represented by the conversion of LC3-I to LC3-II and the
decrease of p62 (Figures 3A and 3B). Atg5 functions as a
complex with Atg12 and Atg16L1 in the degradative autophagy
pathway. Thus, we further assessed the requirement for the
Atg12-Atg5-Atg16L1 complex in the IFN-g-mediated control
of T. gondii by utilizing Atg5 mutants and Atg7-deficient
(Atg7flox/flox+LysMcre) and Atg16L1-deficient (Atg16L1flox/flox+
LysMcre) macrophages. In contrast to WT Atg5, the Atg12
conjugation-defective mutant (Atg5-K130R) (Mizushima et al.,
1998) and Atg16L1 binding-defective mutants (partial defective
Atg5-D88A and severely defective Atg5-G84A-D88A) of Atg5
(Hwang et al., 2012) were not able to restore the control ofImmunity 40, 924–9T. gondii by IFN-g (Figure 3A) or basal
autophagy (Figure 3B) in the Atg5-defi-
cient macrophages. These data suggest
that the conjugation of Atg12 to Atg5
and the binding of Atg5 to Atg16L1 are
required for IFN-g to control T. gondii
infection.
T. gondii infection was not inhibited by
IFN-g in Atg7-deficient macrophages,
but transduction with WT Atg7 restored
the control of T. gondii by IFN-g, as well
as basal autophagy in Atg7-deficient
macrophages (Figures 3C and 3D). How-
ever, an enzyme null mutant of Atg7(Atg7/C567A) (Fujita et al., 2008) was not able to restore either
the control of T. gondii by IFN-g or basal autophagy (Figures
3C and 3D). It was recently shown that autophagic sequestration
of invading bacteria and the subsequent degradation of the
cargo (called xenophagy) can be targeted through the ubiquiti-
nation of the endosomes that contain the invading bacteria
(Fujita et al., 2013; Levine et al., 2011). The elongation complex
localizes and directs LC3 to the ubiquitinated target because
Atg16L1 recognizes the ubiquitinated substrates via three inde-
pendent mechanisms. First, Atg16L1 directly binds to ubiquitin
via the WD repeat domain at its C terminus. Second, Atg16L1
binds to FIP200 in the initiation complex, which is recruited to
the ubiquitinated target independently. This interaction is also
required for the proper targeting of Atg16L1 to the site of auto-
phagosome initiation for canonical autophagy (e.g., starvation-
induced) (Gammoh et al., 2013; Nishimura et al., 2013). Third,
amino acids 194–195 of Atg16L1 play a role through an unknown
mechanism (Fujita et al., 2013). We therefore reconstituted35, June 19, 2014 ª2014 Elsevier Inc. 927
Figure 3. Atg12-Atg5-Atg16L1 Complex Formation via Atg7 Is Required for IFN-g to Control T. gondii Infection
(A) Flow cytometry analysis for T. gondii infection ± 24 hr pretreatment of 100 U/ml of IFN-g at 24 hpi (MOI = 1) inAtg5flox/flox+/LysMcreBMDMs transducedwith
control, WT Atg5 or mutants: K130R—defective in Atg12 conjugation, D88A and G84A/D88A—defective in Atg16L1 binding.
(B) Protein blot for untreated or uninfected samples as shown in (A).
(C) Same analysis as shown in (A) for Atg7flox/flox+/LysMcre BMDMs transduced with control, WT Atg7, or enzyme null mutant (C567A).
(D) Protein blot for untreated or uninfected samples as shown in (C).
(E) Same analysis as shown in (A) for Atg16L1flox/flox+/LysMcre BMDMs transduced with control, dWDR (WD repeat deletion), dWDR(239-242)A (+FIP200
binding defective), dWDR(194-195)A (+ mutated 194th-195th), and dWDR(239-242)A(194-195)A.
(F) Protein blot for untreated and uninfected samples as shown in (E). Statistical analysis by one-way ANOVA with Tukey post test. *p < 0.05, **p < 0.01, ***p <
0.001, ****p < 0.0001. Combined data as average ± SEM. See also Figure S3.
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Atg16L1 and investigated the IFN-g-mediated control of
T. gondii. As observed for Atg5- and Atg7-deficient macro-
phages, T. gondii infection was not controlled by IFN-g in the928 Immunity 40, 924–935, June 19, 2014 ª2014 Elsevier Inc.absence of Atg16L1 (Figure 3E). Upon transduction of WT
Atg16L1 and its WD repeat deletion mutant (dWDR), the control
of T. gondii by IFN-g and basal autophagy were restored (Figure
S3B; Figures 3E and 3F). Further, transduction of FIP200-binding
Figure 4. Atg3 Is Required for the Control of
T. gondii Infection
(A) Flow cytometry analysis for T. gondii infection
at 24 hpi (MOI = 1) in Atg3flox/flox+/LysMcre
BMDMs ± 24 hr pretreatment of IFN-g at the
indicated doses.
(B) Protein blot for untreated or uninfected
Atg3flox/flox+/LysMcre BMDMs.
(C) Protein blot for WT and Atg3/ MEF.
(D) Same analysis as shown in (A) for the WT and
Atg3/ MEF.
(E) Survival curves of Atg3flox/flox+/LysMcre
mice after intraperitoneal inoculation with T. gondii.
(F) Protein blot for untreated or uninfected sam-
ples as shown in (G) ovx, overexpressed; end,
endogenous.
(G) Same analysis as shown in (A) for WT and
Atg3/ MEFs transduced with control, WT Atg3,
or its enzyme null mutant (C264S) +/ 24 hr pre-
treatment of 100 U/ml of IFN-g. Statistical analysis
byone-wayANOVAwithTukeypost test or log rank
(Mantel-Cox) test. n.s., not significant (p > 0.05),
**p < 0.01, ***p < 0.001, ****p < 0.0001. Combined
data as average ± SEM. See also Figure S3.
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mutations in amino acids 194–195, dWDR(194-195)A, of WD
repeat deletion mutant as well as triple mutant, dWDR(239–
242)A(194–195)A (Fujita et al., 2013), restored the control of
T. gondii by IFN-g significantly (Figure 3E). However, those
mutants did not fully restore basal autophagy (no significant
reduction in p62 level) while LC3-II conversion was restored (Fig-
ure 3F). These data suggest that the C-terminal WD repeat
domain, binding to FIP200, and concomitant ubiquitin-binding
activity of Atg16L1 are not required for IFN-g-mediated control
of T. gondii and that the N-terminal conserved domain of
Atg16L1, which includes a domain for Atg5-binding, is sufficient
for its function. Taken together, all these data suggest that the
whole elongation complex of Atg12-Atg5-Atg16L1 is required
for IFN-g to control T. gondii infection in vitro and further indi-
cated that the function of Atg12-Atg5-Atg16L1 complex in the
control of T. gondii by IFN-g is different from its role in canonical
autophagy and ubiquitin-dependent xenophagy.Immunity 40, 924–9Atg3 Is Required for IFN-g to
Control T. gondii Infection
The only known function of the Atg12-
Atg5-Atg16L1 complex so far is to pro-
vide an E3 ligase activity for the targeted
conjugation of LC3 homologs to phos-
phatidylethanolamine on the growing
autophagosome (Rubinsztein et al.,
2012). Although the canonical autophagy
pathway is not required for IFN-g to con-
trol T. gondii infection, it was still possible
that the conjugation of LC3 homologs to
membranes through the E3 ligase activity
of the complex is required. To investigate
the requirement for LC3 conjugation in
the control of T. gondii by IFN-g, we
utilized Atg4B- and Atg3-deficient mac-rophages because of the redundancy of LC3 family members
in mammalian system (Shpilka et al., 2011). Atg4B is the domi-
nant isoform of Atg4 in macrophages that is required for the
proteolytic processing of LC3 homologs for both conjugation
to and deconjugation from autophagosomal membranes
(Hwang et al., 2012; Marin˜o et al., 2010). Atg3 is the essential
E2 enzyme only for the conjugation of LC3 homologs (Sou
et al., 2008), although Atg7 is required for conjugation of both
Atg12 and LC3 homologs. In Atg4B-deficient macrophages,
T. gondii infection was controlled by IFN-g significantly better
than its control macrophages (Figure S3C). In contrast, in
Atg3-deficient macrophages T. gondii infection was controlled
by IFN-g significantly less than in control macrophages (Fig-
ure 4A). Because the deletion of Atg3 by Cre recombinase in
the macrophages was not complete (Figure 4B), we obtained
MEFs with complete functional deficiency of Atg3 (Atg3/, Fig-
ure 4C) and confirmed that T. gondii infection was not controlled
by IFN-g (Figure 4D), which is consistent with the recent findings35, June 19, 2014 ª2014 Elsevier Inc. 929
Figure 5. LC3 and Irga6 Localize on the PVM of T. gondii
A representative image of immunofluorescence for WT MEF at 2 hpi (MOI = 1)
of T. gondii infection with 24 hr pretreatment of 100 U/ml of IFN-g. Experiments
were performed more than thrice.
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Autophagy Proteins Targeting Vacuole of Pathogenof others (Haldar et al., 2014). We further examined the physio-
logical significance of Atg3 during the in vivo T. gondii infection
by infecting Atg3flox/flox+LysMcre and littermate control mice
with T. gondii. Consistent with the in vitro data, micewithmyeloid
lineage specific deletion of Atg3 were significantly more sus-
ceptible to the lethal infection of T. gondii than control mice
(Figure 4E). We further examined the importance of E2 enzyme
activity of Atg3 in the IFN-g-mediated control of T. gondii by
transducing Atg3/ MEF with WT and enzyme null mutant
(C264S) of Atg3 (Figure 4F) (Sou et al., 2008). T. gondii infection
was significantly controlled by IFN-g in Atg3/MEF transduced
with WT Atg3 but not with the enzyme null mutant, demon-
strating that the E2 enzyme activity of Atg3 is required for the
control of T. gondii by IFN-g (Figure 4G). Thus, E2 conjugating
enzyme Atg3, in addition to E1 activating enzyme Atg7 and E3
ligase Atg12-Atg5-Atg16L1 complex, is required for the IFN-g-
mediated control of T. gondii infection in vitro and in vivo.
Colocalization of LC3 with the Parasitophorous Vacuole
Membrane of T. gondii
We and others have showed that Atg5 is required for the proper
targeting of the IFN-g-induced effectors to the PVM of T. gondii
without the involvement of autophagosome (Selleck et al., 2013;
Zhao et al., 2009; 2008). One plausible mechanism based on our
data was that the conjugation of LC3 homologs plays a crucial
role in the recruitment of the IFN-g effectors onto the PVM of
T. gondiiwithout the involvement of functional modules for auto-
phagosome initiation or nucleation and lysosomal degradation.
Therefore, we reasoned that LC3 homologs might be directly
conjugated onto the PVMof T. gondii. However, it was previously
shown that GFP-LC3, conventional marker for autophagosomal
membrane, does not colocalize with the PVM of T. gondii (Mar-
tens et al., 2005). Because a discrepancy in cellular localization
and function between the N-terminal GFP-tagged LC3 and
endogenous LC3 has been reported (Reggiori et al., 2010),
we examined the localization of endogenous LC3 with regard
to invading T. gondii and IFN-g-induced effectors, such as
immunity-related GTPase 6 (Irga6, a.k.a. IFN-inducible GTPase
1, IIGP1). We first investigated the localization of LC3 in non-
phagocytic cells, MEFs, because LC3 can be recruited to the930 Immunity 40, 924–935, June 19, 2014 ª2014 Elsevier Inc.phagosomal single membrane (Sanjuan et al., 2007). Live
T. gondii enters cells by an active parasite-driven process that
is independent of phagocytosis (Sibley, 2011). At 2 hr postinfec-
tion (hpi) of IFN-g-treated MEFs, Irga6 localized on the PVM of
T. gondii and the colocalization of endogenous LC3 with Irga6
was detected on the PVM (Figure 5). Therefore, endogenous
LC3 can localize on or near the PVMof T. gondii and, considering
the absence of double-membrane-bound autophagosome near
the PVM (Zhao et al., 2008) and the necessity of LC3 conjugation
machinery for the control of T. gondii by IFN-g, it is highly likely
that LC3 is conjugated to the PVM of T. gondii.
Atg5 and Atg3, but Not Atg14L, Are Required for the
Localization of LC3 and Irga6 on the PVM
To examine the genetic requirement of LC3 and Irga6 localization
on the PVM of T. gondii, we further investigated their localization
with regard to invading T. gondii in Atg5- and Atg14L-deficient
macrophages, as well as in Atg3/ MEFs. In IFN-g-treated
control macrophages, Irga6 and LC3 localized on the PVMs of
T. gondii both individually and concurrently (Figure 6A). Even in
untreated macrophages, LC3 alone localized on the PVM of a
small percentage of T. gondii in the absence of Irga6, suggesting
that the localization of LC3 on the PVM of T. gondii is not depen-
dent on induction or recruitment of IFN-g effectors. In contrast, in
Atg5-deficient macrophages the localizations of LC3 and Irga6
on the PVM of T. gondii were significantly reduced and Irga6
formed cytoplasmic aggregates as shown previously (Zhao
et al., 2008). These data demonstrate that Atg5 is required for
the proper targeting of both LC3 and Irga6 to the PVM of
T. gondii, as well as for the control of T. gondii by IFN-g.
In contrast to Atg5-deficient macrophages, in Atg14L-defi-
cient macrophages there was no reduction in the localization
of LC3 and Irga6 to the PVM of T. gondii (Figure 6B) and Irga6
did not form aggregates, indicating that localization of LC3 and
Irga6 onto the PVM as well as the control of T. gondii by IFN-g
do not require a gene essential for canonical degradative auto-
phagy. However, in Atg3/ MEFs, LC3 did not localize on the
PVM of T. gondii and Irga6 formed cytoplasmic aggregates (Fig-
ure 6C). Again, LC3 was detected on the PVMof a small percent-
age of T. gondii even in the absence of IFN-g treatment, confirm-
ing that the localization of LC3 on the PVM requires functional
Atg3, but not IFN-g. Collectively, our data demonstrated that
Atg5 and Atg3, but not Atg14L, are required for the localization
of LC3 and Irga6 on the PVM of T. gondii and that LC3 localizes
on the PVM of T. gondii independent of IFN-g.
The Ubiquitin-like Conjugation Systems Are Required
for the Localization of IFN-g Effectors onto PVM
We confirmed that another member of the IRG family (Irgb6, Fig-
ure 7A) and GBPs (GBP1-5, Figure 7B) (Howard et al., 2011; Kim
et al., 2012) were also recruited onto the PVM of T. gondii only
in the presence of Atg3 and Atg7. Further, when we tested the
control of endodyogenic replication of T. gondii within a parasi-
tophorous vacuole by IFN-g, IFN-g also significantly reduced
the replication of T. gondii in the vacuole, in an Atg3- and
Atg7-dependent manner (Figure S4A). Lastly, to examine the
necessity of the enzyme activity of the Atg3 and Atg7 in the
recruitment of IFN-g effectors onto the PVM of T. gondii, we re-
constituted Atg3/ and Atg7/MEFs with WT and catalytically
Figure 6. Atg5 and Atg3, but Not Atg14L, Are Required for the Localization of LC3 and Irga6 on the PVM of T. gondii
(A–C) Representative images (left) and quantitation (right) of immunofluorescence for T. gondii, LC3, and Irga6 in (A) Atg5flox/flox+/LysMcre and (B)
Atg14Lflox/flox+/LysMcre BMDMs and (C) Atg3 WT and Atg3/MEFs at 2 hpi (MOI = 1) of T. gondii infection ± 24 hr pretreatment of 100 U/ml of IFN-g. At least
100 cells infected with T. gondii were analyzed for quantitation. Statistical analysis by one-way ANOVA with Tukey post test. n.s., not significant (p > 0.05), **p <
0.01, ***p < 0.001, ****p < 0.0001. Combined data as average ± SEM.
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(Figure 4F; Figure S4B). Consistent with the genetic data (Figures
3C and 4G), WT Atg3 and Atg7 were able to restore the recruit-
ment of Irga6 onto the PVM of T. gondii in Atg3/ and Atg7/
MEF, respectively (Figures 7C and 7D). However, catalytically
inactive mutants of Atg3 and Atg7 were incapable of restoring
the recruitment of the IFN-g effector onto the PVM. Collectively,
these data demonstrate the essential role of the ubiquitin-like
conjugation systems of the autophagy pathway in the recruit-
ment of IFN-g effectors onto the PVM of T. gondii and
subsequent control of T. gondii infection and replication.
DISCUSSION
Degradative autophagy has been shown to play crucial roles in
immune defense against intracellular pathogens, as well as its
conventional roles in recycling and remodeling (Levine et al.,
2011). In addition, the evolutionarily conserved autophagy pro-
teins have evolved and acquired unique functions in the immunesystemandmyeloid cells, independent of their roles in the degra-
dation pathway (Bestebroer et al., 2013; DeSelm et al., 2011;
Hwang et al., 2012; Reggiori et al., 2010; Starr et al., 2012;
Subramani and Malhotra, 2013). In this report, we extended
these observations by demonstrating that the ubiquitin-like
conjugation machinery of the autophagy pathway, E1 Atg7, E2
Atg3, and E3 Atg12-Atg5-Atg16L1, are required for the proper
targeting of IFN-g effectors onto the PVMof T. gondii and subse-
quent control of in vitro and in vivo T. gondii infection. Although
degradative autophagy has been proposed to play a role in the
CD40 ligation-mediated defense against T. gondii in nonhemato-
poietic cells (Van Grol et al., 2013), the multiple aspects of the
overall autophagy pathway including the ULK1 and ULK2 initia-
tion complex, the Atg14L nucleation complex, and lysosomal
degradation were not required for the control of T. gondii by
IFN-g in MEFs or macrophages. We further found that LC3 local-
ized on, and possibly was conjugated to, the PVM of T. gondii,
and we confirmed that the recruitment of IFN-g effectors to the
PVM was dependent on the functional ubiquitin-like conjugationImmunity 40, 924–935, June 19, 2014 ª2014 Elsevier Inc. 931
Figure 7. The Ubiquitin-Like Conjugation
Systems of the Autophagy Pathway Are
Required for the Localization of IFN-g Effec-
tors onto the PVM of T. gondii Infection
(A and B) Immunofluorescence of MEFs at 2 hpi
(MOI = 1) of T. gondii infection with 24 hr pre-
treatment of 100 U/ml of IFN-g. Representative
images (left) and quantitation (right) of immuno-
fluorescence. Irgb6 (A) and GBP1-5 (B) in WT,
Atg3/ and Atg7/MEFs. At least 50 of infected
T. gondiiwere analyzed for quantitation. Statistical
analysis by one-way ANOVA with Tukey post
test. ****p < 0.0001. Experiments were performed
twice. Combined data as average ± SEM.
(C) T. gondii and Irga6 in Atg3 WT and Atg3/
MEFs transduced with control (GST, glutathione
S-transferase), WT Atg3, or enzyme null mutant
(C264S).
(D) T. gondii and Irga6 in Atg7 WT and Atg7/
MEFs transduced with control (GST), WT Atg7,
or enzyme null mutant (C567A). At least 100 of
infected T. gondii were analyzed for quantitation.
Statistical analysis by unpaired t test. n.s., not
significant. *p < 0.05, **p < 0.01. Experiments were
performed twice. Combined data as average ±
SEM. See also Figure S4.
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ubiquitin-like conjugation systems utilized for the reorganization
of intracellular membranes in the canonical autophagy pathway
have evolved to target immune effectors toward the intracellular
vacuole membrane structure of pathogens.
Although IRGs and GBPs are thought to participate in disrupt-
ing the PVM, the molecular mechanism of their recruitment to
this interface through Atg5 is incompletely understood (Howard
et al., 2011). The autophagosome itself is not directly involved
in the control of T. gondii per se (Zhao et al., 2009; 2008). Never-
theless, it was possible that a functional degradative autophagy
pathway might be required to remove prematurely activated
IFN-g effectors, which tend to aggregate and subsequently
inhibit the proper loading of the effectors on the target932 Immunity 40, 924–935, June 19, 2014 ª2014 Elsevier Inc.membrane (Selleck et al., 2013). In this
setting, one might predict that the entire
degradative autophagy pathway and all
essential autophagy proteins are required
for proper effector function. However,
our data clearly demonstrated that the
degradative autophagy pathway and the
other functional cassettes of autophagy
proteins were not required for efficient
control of T. gondii by IFN-g. In fact, un-
like the situation for Atg5-deficient cells,
we did not detect any aggregation of the
activated IFN-g effectors in Atg14L-defi-
cient macrophages, even though canoni-
cal autophagy was significantly inhibited.
Thus, our current data do not support
the role of degradative autophagy for
the proper maintenance of activated
IFN-g effectors.Independent of IFN-g effector targeting to T. gondii, LC3 local-
ized on a small percentage of PVMs in a ubiquitin-like conjuga-
tion-system-dependent process. This finding is reminiscent of
Atg16L1 localization on the membranous replication complex
of MNV without IFN-g-treatment (Hwang et al., 2012). The
Atg12-Atg5-Atg16L1 complex, particularly Atg16L1, can specify
the lipidation site of LC3 for the membrane biogenesis in both
nonselective autophagy (Fujita et al., 2008) and selective xen-
ophagy (Fujita et al., 2013). Thus, it is tempting to speculate
that the Atg12-Atg5-Atg16L1 complex might function as a
module to recognize and/or mark the ‘‘nonself’’ intracellular
membrane structure of pathogens through the conjugation of
LC3. The conjugated LC3 might recruit the effectors through
direct interaction or indirectly through adaptor proteins in a
Immunity
Autophagy Proteins Targeting Vacuole of Pathogensimilar way to its function in canonical autophagy (Shpilka et al.,
2011). Alternatively, although the localization of LC3 on the PVM
of T. gondii happened even in nonphagocytic cells, it is still
possible that these events might represent parasites that were
engulfed by cellular processes other than pathogen-driven inva-
sion. Resolving these respective roles will take further studies on
the kinetics of LC3 recruitment to PVMs in non-IFN-g-treated
cells.
Interestingly, T. gondii infection was controlled by IFN-g
more efficiently in Atg4B-deficient cells than in control cells,
which also happened in the control of MNV by IFN-g (Hwang
et al., 2012). A major function of Atg4 family proteins is to
cleave the membrane-bound LC3, as well as to proteolytically
process LC3 for membrane conjugation. Thus, in the absence
of Atg4B, the deconjugation or delipidation of LC3 from the
membrane is slowed down, which might lead to the more
recruitment of the IFN-g effectors and thus more efficient con-
trol of pathogens by IFN-g. In this regard, it is interesting to
note that Atg4B can be recruited onto the membrane structure
of pathogens by one of the IFN-g effectors, GBP7 (Kim et al.,
2011). The recruitment of Atg4B to the membrane by the IFN-
g effectors and subsequent cleavage of LC3 from the mem-
brane might be a negative feedback mechanism for proper
activity of IFN-g effectors.
Although both LC3 and the IFN-g effector Irga6 localized
on the PVM of T. gondii, there was relatively little concurrent co-
localization between LC3 and Irga6 on the PVM. These data
suggest that LC3 and the IFN-g effectors might not work simul-
taneously and their recruitment to the PVM of T. gondiimight be
spatially and temporally regulated for efficient targeting and
disruption of the membrane structure of the pathogens. Alterna-
tively, the ubiquitin-like conjugation system of the autophagy
pathway might be required for some yet-undefined role that
is necessary for proper homeostasis of the IFN-g effectors,
because they form aggregates when these autophagy proteins
are absent. Indeed, it was previously proposed that Atg5 might
be required for the normal function of regulatory IRGs (GMS sub-
family, e.g., Irgm1, Irgm3) to demarcate endosomal membranes
and special pathogen-oriented membranes and/or to regulate
nucleotide exchange and activation of the effector IRGs (GKS
subfamily, e.g., Irga6, Irgb6) (Haldar et al., 2013; Hunn et al.,
2008). This explanation is not mutually exclusive with the mech-
anisms proposed here. Further studies are required to elucidate
how the conjugation of LC3 homologs by the ubiquitin-like
conjugation systems determines the recruitment of the IFN-g
effectors onto the PVM of T. gondii.
It is interesting to note that a similar dependence on Atg5
and Atg7 and targeting of LC3 to single membranes has been
observed for the secretion of lysosomal proteins by osteoclasts
and mucin by colonic goblet cells, LC3-associated phagocytosis
(LAP), and entotic cell engulfment (DeSelm et al., 2011; Florey
et al., 2011; Martinez et al., 2011; Patel et al., 2013). Particularly,
considering the enhanced killing of phagocytosed microbes
through LAP (Sanjuan et al., 2007), it will be important to further
study the shared and differentiated mechanism between LAP
and the process described here that targets intracellular mem-
brane structures in host immune defense. Notably, the parasito-
phorousvacuoleofT.gondii is activelymadeby thepathogen itself
even in nonphagocytic cells, suggesting that, even if the samemachinery is required by both LAP and destruction of intracellular
T.gondii, themembraneevents involvedmightdiffer topologically.
Our findings confirm and extend recently published findings
showing the critical role of Atg3, Atg7, and Atg16L1, but not
Atg9a and Atg14, for the control of T. gondii by IFN-g effectors
(Haldar et al., 2014; Ohshima et al., 2014). The data we provide
here show in vivo relevance and molecular proof of the specific
functions of the required autophagy proteins (e.g., enzymatic ac-
tivity of Atg3 and Atg7, binding of Atg5 to Atg16L1) in intracellular
killing of T. gondii. Importantly, we also show here the functions
of the autophagy proteins in macrophages, primary cells that
are involved in resistance to T. gondii. Thus, our study firmly
demonstrated the nondegradative function of ubiquitin-like
conjugation systems of the autophagy pathway in cell-autono-
mous immune defense system. Together, these studies estab-
lish the paradigm that autophagy proteins function in intracellular
immunity in ways that do not require the entire degradative auto-
phagy pathway.
In summary, we found that the ubiquitin-like conjugation
machinery of the autophagy pathway, but not the degradative
autophagy pathway itself, plays crucial roles in the antiparasitic
activity of IFN-g in that it is required for the proper targeting of
the IFN-g effectors to the vacuole membrane structure of the
parasites. Elucidating such nondegradative roles of autophagy
proteins in sensing and inducing the destruction of pathogenic
membrane structures in the cytoplasm might lead to novel
therapeutic and/or prophylactic treatments for the infectious
diseases caused by these pathogens, as well as to a greater
appreciation and understanding of fundamental biological pro-
cesses of the genes in the autophagy pathway. The evolutionary
conservation of autophagy from the earliest stages of metazoan
evolution might have favored the diversification of autophagy
proteins to contribute differentially to host defense and thereby
to play key roles both through degradative functions of auto-
phagy and through other, perhaps as yet undiscovered, mecha-
nisms of intracellular immunity.
EXPERIMENTAL PROCEDURES
Mice and Cells
Atg5flox/flox+/LysMcre, Atg7flox/flox+/LysMcre, Atg16L1flox/flox+/LysMcre
mice were previously described (Hwang et al., 2012). Atg14Lflox/flox+/
LysMcre mice were kindly provided by Dr. Shizuo Akira, Osaka University,
Japan. Atg3flox/flox+/LysMcremice were derived from Atg3flox/flox mice kindly
provided by Dr. You-Wen He, Duke University, USA (Jia and He, 2011). All
mice were housed and bred at Washington University and University of Chi-
cago under specific-pathogen-free conditions in accordance with federal
and university guidelines. Bone-marrow-derived macrophages (BMDMs),
MEFs, and 293T cells were used for T. gondii infection and lentiviral transduc-
tion. See the Supplemental Experimental Procedures for the details.
Infection with T. gondii
T. gondii (type II strains) expressing luciferase (ME49) and green fluorescent
protein (PTG) were maintained in HFF cells (Zhao et al., 2008). At the time of
infection, an inoculum of infectious T. gondii tachyzoites was prepared by dis-
rupting the infected HFF cells with 26G needle and syringe, centrifuging the
lysate at 4003 g for 10 min, and resuspending the precipitate in culture media
(in vitro) or serum-free DMEM (in vivo). For in vitro experiments, cells were
pretreated with recombinant murine IFN-g at the indicated doses (e.g.,
100 U/ml = 50 ng/ml) for 24 hr, infected with T. gondii tachyzoites at the mul-
tiplicity of infection (MOI) of 1. At 24 hr postinfection (hpi), the infected cells
were fixed with 2% formaldehyde (Ted Pella; 18505) in PBS for 10–20 min atImmunity 40, 924–935, June 19, 2014 ª2014 Elsevier Inc. 933
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X-100 (PBS-T) overnight at 4C, and T. gondii infection was assessed by
indirect immunofluorescence or flow cytometry. For in vivo experiments of
Atg5flox/flox+/LysMcre, Atg7flox/flox+/LysMcre, Atg14Lflox/flox+/LysMcre,
and Atg16L1flox/flox+/LysMcremice, 9- to 11-week-old mice were inoculated
intraperitoneally with 200 (male) or 100 (female) of T. gondii tachyzoites per
mouse (Zhao et al., 2008), and the survival of the infected mice was monitored
for 30 days in accordance with the guideline of Washington University. No sig-
nificant phenotypic difference was observed between male and female mice.
The T. gondii infection study ofAtg3flox/flox+/LysMcremicewere performed in
the presence of 0.6 ug/ml buprenorphine under the guideline of University of
Chicago. Two or three independent experiments were done for each in vivo
infection study.
Chemicals
Rapamycin (sc-3504, 5 mM in DMSO), wortmannin (sc-3505, 5 mM in DMSO),
bafilomycin A1 (sc-201550, 100 uM in DMSO), E64D (sc-201280, 5 mg/ml in
DMSO), and pepstatin A (sc-45036, 5 mg/ml in DMSO) were from Santa
Cruz Biotechnology; chloroquine (C6628, 20 mM in water) was from Sigma;
LY294002 (#9901, 10 mM in DMSO) was from Cell Signaling; and mouse
IFN-g (485MI/CF, 200 U/ul (100 ng/ul) in PBS/0.1%BSA) was from R&D
Systems.
Protein Analysis by Immunoblot
Total cellular proteins were harvested and proteins were analyzed as previ-
ously described (Hwang et al., 2012). Peritoneal exudate cells (PECs) were
obtained by lavage, incubated at 37C for 4 hr on tissue-culture-treated plates,
and washed to purify adherent macrophages. Cell lysates were then harvested
and analyzed by immunoblot. Commercial antibodies used in this study are
as follows: 2A (Millipore, ABS31), Atg3 (MBL, M133-3), Atg7 (Sigma, A2856),
Atg14L (Sigma, A6358), Atg16L1 (Sigma, A7356), Beta-actin (Sigma, A5316),
LC3B (Sigma, L7543), and p62 (Sigma, P0067).
Immunofluorescence and Flow Cytometry
Fixed and permeabilized cells were analyzed for T. gondii infection by
immunofluorescence and flow cytometry with rabbit polyclonal anti-GRA7
(dense granule protein 7) (Selleck et al., 2013) or GFP-expressing reporter stain
(PTG). See the Supplemental Experimental Procedures for the details.
Statistical Analysis
All data were analyzed with Prism software (GraphPad). Unless otherwise
stated, all experiments were performed at least three times, and the data
were combined for presentation as average ± SEM. All differences not specif-
ically indicated to be significant were not significant (n.s., p > 0.05). *p < 0.05,
**p < 0.01, *** p < 0.001, ****p < 0.0001.
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